Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer

Overview of attention for article published in JCO Precision Oncology, April 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 16,157 followers.

https://t.co/ZCT09KBqJO Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer. - PubMed - NCBI https://t.co/aosUPEmgX7 PubMed comprises more than 29 million citations for biomedical literature from MEDLINE, life science jo

04 Aug 2019

Reply Repost Favourite

Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer. https://t.co/7MHw4Adgj5

04 Aug 2019

Reply Repost Favourite

RT @treehousecancer: Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer | @ASCO JCO Precision Oncology h…

10 May 2018

Reply Repost Favourite

RT @treehousecancer: Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer | @ASCO JCO Precision Oncology h…

09 May 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.